Dr. Mike Jackson has long studied the spread of flu and effectiveness of vaccination at Kaiser Permanente Washington. And now… of COVID-19 too.
Led by Dr. Lisa A. Jackson, first-ever trial of any experimental vaccine candidate for COVID-19 virus has expanded.
From clinical trials to technical support, Dr. Rita Mangione-Smith describes how Kaiser Permanente Washington researchers are fighting the novel coronavirus.
On March 16, 4 volunteers received an injection of an mRNA vaccine for COVID-19 in NIH-funded trial in Seattle.
The benefits of vaccines far outweigh the risks. Still, the debate about the value of vaccines continues on. Here are some facts to help you make the right health decision for your child.
There’s a lot of information out there about the merits and risks of vaccines. Parents are rightly concerned about making the best choices for their children amid conflicting information.
Dr. Paula Lozano describes an effort to find KP Washington members who would benefit most from preventive services.